Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBCWW) Non Operating Income (2023 - 2025)

Historic Non Operating Income for SBC Medical Group Holdings (SBCWW) over the last 3 years, with Q3 2025 value amounting to $2.6 million.

  • SBC Medical Group Holdings' Non Operating Income rose 46128.2% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.2 million, marking a year-over-year increase of 63599.54%. This contributed to the annual value of $3.2 million for FY2024, which is 797.59% up from last year.
  • Per SBC Medical Group Holdings' latest filing, its Non Operating Income stood at $2.6 million for Q3 2025, which was up 46128.2% from -$1.0 million recorded in Q2 2025.
  • In the past 5 years, SBC Medical Group Holdings' Non Operating Income ranged from a high of $7.2 million in Q1 2025 and a low of -$1.0 million during Q2 2025
  • In the last 3 years, SBC Medical Group Holdings' Non Operating Income had a median value of $1.0 million in 2023 and averaged $1.4 million.
  • Data for SBC Medical Group Holdings' Non Operating Income shows a peak YoY increase of 46128.2% (in 2025) and a maximum YoY decrease of 39667.16% (in 2025) over the last 5 years.
  • Over the past 3 years, SBC Medical Group Holdings' Non Operating Income (Quarter) stood at -$424180.0 in 2023, then soared by 416.3% to $1.3 million in 2024, then surged by 95.7% to $2.6 million in 2025.
  • Its last three reported values are $2.6 million in Q3 2025, -$1.0 million for Q2 2025, and $7.2 million during Q1 2025.